Jenburkt Pharmaceuticals Limited (BOM:524731)

Market Cap	5.86B
Revenue (ttm)	1.52B
Net Income (ttm)	320.61M
Shares Out	4.41M
EPS (ttm)	72.65
PE Ratio	18.29
Forward PE	n/a
Dividend	18.00 (1.36%)
Ex-Dividend Date	Jul 11, 2025

Volume	744
Average Volume	1,447
Open	1,375.00
Previous Close	1,367.70
Day's Range	1,320.00 - 1,384.00
52-Week Range	815.80 - 1,410.00
Beta	0.48
RSI	52.61
Earnings Date	Jul 29, 2025

About Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals Limited is a manufacturer and marketer of Pharmaceutical Formulations and Healthcare Products in India and internationally. The company offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, antifungals, antiulcerants/antacids, aphrodisiacs, antimalarials, anthelmintics, cough and cold, and anti-diabetics, as well as consumer products. The company offers its products under the Allerzine, Cart...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 779
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524731

Financial Performance

In 2024, Jenburkt Pharmaceuticals's revenue was 1.52 billion, an increase of 6.85% compared to the previous year's 1.42 billion. Earnings were 320.61 million, an increase of 23.42%.